Table 2 Subgroup analysis especially for gender as sensitivity analysis for the outcomes
From: A five-year longitudinal study of the relation between end-stage kidney disease as the outcomes
Variable | Category | Female | Male | ||
|---|---|---|---|---|---|
n | % | n | % | ||
Diabetes | No | 48 | 60.00 | 30 | 44.12 |
Yes | 32 | 40.00 | 38 | 55.88 | |
Hypertension | No | 14 | 17.50 | 5 | 7.35 |
Yes | 66 | 82.50 | 63 | 92.65 | |
Dyslipidemia | No | 65 | 81.25 | 54 | 79.41 |
Yes | 15 | 18.75 | 14 | 20.59 | |
Cardiovascular disease | No | 71 | 88.75 | 63 | 92.65 |
Yes | 9 | 11.25 | 5 | 7.35 | |
Ischemic heart disease | No | 71 | 88.75 | 59 | 86.76 |
Yes | 9 | 11.25 | 9 | 13.24 | |
Heart failure | No | 50 | 62.50 | 47 | 69.12 |
Yes | 30 | 37.50 | 21 | 30.88 | |
Coronary atherosclerotic heart disease | No | 50 | 62.50 | 37 | 54.41 |
Yes | 30 | 37.50 | 31 | 45.59 | |
Anemia | No | 42 | 52.50 | 34 | 50.00 |
Yes | 38 | 47.50 | 34 | 50.00 | |
Heart arrhythmia | No | 64 | 80.00 | 54 | 79.41 |
Yes | 16 | 20.00 | 14 | 20.59 | |
Atrial fibrillation | No | 76 | 95.00 | 66 | 97.06 |
Yes | 4 | 5.00 | 2 | 2.94 | |
Cerebrovascular accident | No | 73 | 91.25 | 55 | 80.88 |
Yes | 7 | 8.75 | 13 | 19.12 | |
Ischemic stroke | No | 77 | 96.25 | 63 | 92.65 |
Yes | 3 | 3.75 | 5 | 7.35 | |
Chronic obstructive pulmonary disease | No | 77 | 96.25 | 65 | 95.59 |
Yes | 3 | 3.75 | 3 | 4.41 | |
Peptic ulcer | No | 61 | 76.25 | 58 | 85.29 |
Yes | 19 | 23.75 | 10 | 14.71 | |